Interleukin 10 and 12 polymorphisms and their association with treatment outcome of patients with chronic hepatitis C infection

A study of interleukin-10 (IL-10) promoter gene polymorphisms and response to therapy in chronic hepatitis C infection in children

Interleukin 28b polymorphisms and therapy response in chronic hepatitis C patients

Relation between interleukin-10 polymorphism and the efficacy of interferone–based therapies in HCV patients

Single nucleotide polymorphism of IL-10 and IL- 28b as predictors to the response of interferon therapy in HCV infected children

Study of prediction of response to pegylated interferon plus ribavirin in hepatitis C patients by IL28B gene variation and its relation to other different predictors

Single nucleotide polymorphism analysis of Oligo adenylate synthatase and Interleukin 1 B genes in chronic HCV associated end stage liver disease

Impact of interferon alpha-2 alleles and anti interferon alpha-2 antibodies in HCV infected patients as predictive factors for response to interferon therapy

Single nucleotide polymorphism (SNP) rs8099917 as a predictive factor of virological response to pegylated interferon plus Ribavirin in treatment of chronic hepatitis c virus patients

Osteopontin gene polymorphism as marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C